Does Wegovy Cause Muscle Loss — and What Can You Do About It?

What the STEP trials showed about lean-mass loss

The STEP 1 trial, published in the New England Journal of Medicine, followed nearly 2,000 adults with obesity over 68 weeks. Participants on semaglutide 2.4mg lost an average of around 15% of their body weight. What received less headline attention was the composition of that loss: a substantial share came from lean tissue rather than fat mass alone. Subsequent analyses of similar GLP-1 trials have put the lean-mass fraction of total weight loss anywhere from roughly a quarter to just under 40%, depending on how body composition was measured and the population studied.

That range matters. Losing weight always involves some lean-tissue reduction, this happens with diet alone too. The clinical question is whether the proportion lost on semaglutide is higher than what calorie restriction alone would produce, and whether it is clinically significant for an individual. For most adults, preserving functional muscle is important for mobility, metabolic rate and long-term health. If you are already asking whether Wegovy can cause muscle loss, you are asking exactly the right question.

There is also an important distinction between muscle mass and muscle strength. Some research suggests strength can be maintained even when total lean mass falls slightly, but this is still an active area of clinical investigation, not a settled reassurance.

Why this happens and who is most at risk

Semaglutide reduces appetite substantially. When total calorie intake drops sharply (which it typically does on treatment) the body draws on available energy stores. Fat stores are the primary target, but lean tissue is also broken down when protein intake is insufficient or physical activity drops. The NHS medicines page for semaglutide notes that treatment should accompany a reduced-calorie diet and increased physical activity, precisely because lifestyle factors shape what kind of weight is lost.

People most likely to lose a disproportionate amount of muscle are those who significantly restrict calories without increasing protein, those who are older (muscle maintenance becomes harder with age), those who were already physically inactive, and those losing weight very rapidly. For anyone in these groups, the question of whether semaglutide causes muscle loss is especially worth raising with a prescriber before and during treatment.

Muscle aches or weakness sometimes accompany treatment too, and our page on whether Wegovy can cause muscle pain covers what is known about that separate but related question, while readers wanting to understand whether Wegovy can cause muscle aches specifically will find a focused breakdown there.

Practical strategies that the evidence supports

The good news is that muscle loss during weight-loss treatment is not fixed, it responds to what you do alongside taking the medicine. The two interventions with the strongest evidence base are resistance exercise and adequate protein intake. Resistance training, two to three sessions per week, has been shown in multiple studies to attenuate lean-mass loss during calorie restriction. Protein targets discussed in the clinical literature typically sit between 1.2 and 1.6 grams per kilogram of body weight per day, though the right figure for you depends on factors only your prescriber or a dietitian can properly assess.

Hydration also matters: nausea from semaglutide can reduce fluid intake, and dehydration compounds fatigue in ways that are sometimes mistaken for muscle weakness. The NHS recommends treatment alongside structured lifestyle support for good reason, treatment is most effective, and muscle is best preserved, when medicine and behaviour change work together.

For a fuller look at how this plays out over the course of treatment, our page on Wegovy and muscle loss goes into more detail on body-composition tracking and what to monitor, and if you have concerns about whether the treatment contributes to muscle wasting over time, that page addresses the distinction between normal lean-mass changes and more significant deterioration. Information about the treatment itself, and how our prescribers think about monitoring, is on our Wegovy overview page.

What to do if you are concerned about muscle loss on Wegovy

Raise it with your prescriber. This is genuinely a case where the clinical team needs to know, because the response depends on your full picture: current dose, rate of weight loss, dietary intake, activity level, age and whether you have any conditions that affect muscle maintenance. A prescriber may adjust the pace of titration, refer you for dietitian input, or review your overall treatment plan. Self-adjusting your dose or stopping without clinical guidance creates its own risks.

If you are considering starting Wegovy and want to understand how our prescribers approach body-composition monitoring, the free consultation at nume is the natural starting point. Every consultation is reviewed the same day by a real, named clinician on our team. You can read more about how we work on our about us page. And if cost context is relevant to your decision, our weight-loss treatments overview sets out what is included in the price. There are no hidden fees and no subscription.

Muscle loss is a real consideration, not a reason to avoid treatment, but a reason to do it properly.